tiprankstipranks
Inventiva SA (FR:IVA)
:IVA
France Market
IVA
Inventiva
RESEARCH TOOLSreports

Inventiva (IVA) Stock News & Sentiment

21 Followers
Premium
Company Announcements
Inventiva SA Bets Big on Pivotal MASH Trial
11d ago
Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints
Premium
Ratings
Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints
21d ago
IVA
Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
Premium
Ratings
Inventiva: Strong Balance Sheet and Late-Stage MASH Candidate Lanifibranor Drive Compelling Buy Rating
2M ago
IVA
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
Premium
Ratings
Positive Buy Rating for Inventiva Driven by Promising Phase 3 Trial and Strong Financial Position
5M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Potential as a Foundational MASH Therapy
6M ago
IVA
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
Premium
Ratings
Inventiva’s Strategic Focus and Financial Stability Drive Buy Rating Amid Promising Phase 3 Trial Progress
7M ago
IVA
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
Premium
Ratings
Buy Rating for Inventiva: Lanifibranor’s Promising Role in Metabolic Disease Treatment
7M ago
IVA
More FR:IVA News >

IVA News on the Web

A Look At Inventiva (ENXTPA:IVA) Valuation After Weaker Full Year 2025 Earnings
Simply Wall St
Neutral
A Look At Inventiva (ENXTPA:IVA) Valuation As NATiV3 Enrollment Completes And Odiparcil Rights Are Sold
Simply Wall St
Bullish
Guggenheim Keeps Their Buy Rating on Inventiva (IVA)
TipRanks News
Bullish
Inventiva (ENXTPA:IVA) Loss Worsening To €175.9m Tests Bullish Efficiency Narratives
Simply Wall St
Neutral
Inventiva price target lowered to $15 from $17 at Stifel
TipRanks News
Bullish
LifeSci Capital Sticks to Their Buy Rating for Inventiva (IVA)
TipRanks News
Bullish
Inventiva management to meet with Piper Sandler
TipRanks News
Bullish
Lanifibranor’s Emerging Role in the MASH Market: Physician Sentiment and Uptake Potential Support a Buy Rating Despite Cash Constraints
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
FR:IVA
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average60%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:IVA’s Media Buzz Sentiment?
1 articles about FR:IVA were published this week. In an average week, 2 articles are published.
    What is FR:IVA’s weekly average amount of articles?
    In an average week, 2 articles about FR:IVA are published.
      What is FR:IVA’s News Sentiment?
      50% of articles about FR:IVA were positive this week, compared to its sector average of 60%.
        General Stocks that are Trending in the News
        JANJanus Living, Inc. Class A
        THXThor Explorations
        0J3FSodexo SA
        0RI8Koninklijke Ahold Delhaize N.V.
        0NPLChristian Dior
        Showing the stocks with the most bullish news sentiment over the past week